Free Trial

Integra LifeSciences (IART) SEC Filings & 10K Form

$30.90
+0.10 (+0.32%)
(As of 05/31/2024 ET)

Recent Integra LifeSciences SEC Filings

DateFilerForm TypeView
05/30/2024
3:40 PM
Integra LifeSciences (Filer)
Form SD
Specialized Disclosure Report  
05/24/2024
3:08 PM
ESSIG STUART (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:53 PM
Integra LifeSciences (Issuer)
Lo Renee Wonlai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:55 PM
HILL BARBARA B (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:56 PM
GRAVES JEFFREY A (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:57 PM
Clay Shaundra (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:59 PM
ESSIG STUART (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:32 PM
BRADLEY KEITH (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:38 PM
Integra LifeSciences (Issuer)
SCHADE CHRISTIAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:38 PM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:39 PM
Integra LifeSciences (Issuer)
Murphy Raymond G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
5:15 AM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
3:39 PM
Integra LifeSciences (Filer)
Form DEF 14A
04/04/2024
3:46 PM
Integra LifeSciences (Filer)
Form ARS
03/13/2024
3:29 PM
Integra LifeSciences (Issuer)
McBreen Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:29 PM
DAVIS ROBERT T. JR. (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:30 PM
De Witte Jan (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:25 PM
Integra LifeSciences (Issuer)
Mosebrook Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:26 PM
Integra LifeSciences (Issuer)
Singh Harvinder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:26 PM
Integra LifeSciences (Issuer)
Knight Lea Daniels (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:14 PM
Integra LifeSciences (Issuer)
Schwartz Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:15 PM
Integra LifeSciences (Issuer)
McBreen Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:16 PM
DAVIS ROBERT T. JR. (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:10 PM
Integra LifeSciences (Issuer)
Singh Harvinder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:12 PM
De Witte Jan (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:13 PM
Integra LifeSciences (Issuer)
Mosebrook Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:22 PM
DAVIS ROBERT T. JR. (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:53 PM
DAVIS ROBERT T. JR. (Reporting)
Integra LifeSciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
5:10 AM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
5:15 AM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
3:43 PM
DAVIS ROBERT T. JR. (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:45 PM
Integra LifeSciences (Issuer)
Schwartz Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:47 PM
Integra LifeSciences (Issuer)
Mosebrook Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
3:49 PM
Integra LifeSciences (Issuer)
McBreen Michael J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
2:30 PM
Champlain Investment Partners, LLC (Filed by)
Integra LifeSciences (Subject)
Form SC 13G/A
02/09/2024
4:49 PM
Capital Research Global Investors (Filed by)
Integra LifeSciences (Subject)
Form SC 13G
02/09/2024
11:05 AM
Integra LifeSciences (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/09/2024
7:40 AM
Integra LifeSciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/19/2024
3:43 PM
De Witte Jan (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:57 PM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
3:45 PM
GRAVES JEFFREY A (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
“This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)

NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it.

A new breakthrough tech could add up to $20 trillion to the U.S. economy.
12/13/2023
3:43 PM
GRAVES JEFFREY A (Reporting)
Integra LifeSciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2023
3:31 PM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
5:30 AM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
3:27 PM
De Witte Jan (Reporting)
Integra LifeSciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2023
3:21 PM
Integra LifeSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2023
5:15 AM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
3:25 PM
De Witte Jan (Reporting)
Integra LifeSciences (Issuer)
Form 4/A
09/05/2023
3:07 PM
Integra LifeSciences (Issuer)
Veillon-Berteloot Chantal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2023
3:10 PM
Integra LifeSciences (Issuer)
Veillon-Berteloot Chantal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
8:15 PM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
4:54 PM
Integra LifeSciences (Subject)
Mosebrook Jeffrey (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/27/2023
4:17 PM
Integra LifeSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/21/2023
3:30 PM
Integra LifeSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IART) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners